Linus Jönsson Selected Research

Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)

1/2006

Lipid management and cholesterol goal attainment in Norway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Linus Jönsson Research Topics

Disease

18	Alzheimer Disease (Alzheimer's Disease) 02/2024 - 01/2003
17	Dementia (Dementias) 01/2024 - 01/2003
6	Cognitive Dysfunction 02/2024 - 06/2005
4	Disease Progression 02/2024 - 09/2002
2	Migraine Disorders (Migraine) 03/2024 - 07/2023
2	Breast Neoplasms (Breast Cancer) 07/2023 - 05/2007
2	Esophageal Atresia 03/2019 - 06/2014
2	Type 2 Diabetes Mellitus (MODY) 05/2006 - 09/2005
2	Hypoglycemia (Reactive Hypoglycemia) 05/2006 - 09/2005
2	Osteoporosis 10/2003 - 01/2003
1	Orthostatic Hypotension (Postural Hypotension) 04/2024
1	Frailty 01/2024
1	Multiple System Atrophy 01/2022
1	Schizophrenia (Dementia Praecox) 01/2020
1	Stroke (Strokes) 01/2020
1	Psychotic Disorders (Schizoaffective Disorder) 01/2020
1	Treatment-Resistant Schizophrenia 01/2019
1	Birth Weight (Birth Weights) 10/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2006
1	Diabetes Mellitus 01/2006
1	Heart Diseases (Heart Disease) 12/2005
1	Asthma (Bronchial Asthma) 05/2004
1	Wrist Fractures 01/2003
1	Chronic Progressive Multiple Sclerosis 01/2002

Drug/Important Bio-Agent (IBA)

4	Amyloid (Amyloid Fibrils)IBA 02/2024 - 01/2022
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2023
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2021 - 01/2003
2	eptinezumabIBA 03/2024 - 07/2023
2	Antipsychotic Agents (Antipsychotics)IBA 01/2020 - 01/2019
2	Hypoglycemic Agents (Hypoglycemics)IBA 05/2006 - 09/2005
2	Alendronate (Alendronate Sodium)FDA LinkGeneric 10/2003 - 01/2003
1	A 19IBA 02/2024
1	hydroxide ionIBA 01/2024
1	Trastuzumab (Herceptin)FDA Link 07/2023
1	Therapeutic UsesIBA 07/2023
1	lecanemabIBA 06/2023
1	RoflumilastIBA 01/2023
1	EpitopesIBA 01/2023
1	Polysaccharides (Glycans)IBA 01/2023
1	Apolipoprotein E4IBA 01/2023
1	rasagiline (Azilect)FDA Link 01/2022
1	Galantamine (Galanthamine)FDA LinkGeneric 01/2021
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2020
1	SiliconesIBA 06/2014
1	Sorafenib (BAY 43-9006)FDA Link 01/2014
1	Axitinib (AG 013736)IBA 01/2014
1	Donepezil (Aricept)FDA LinkGeneric 10/2012
1	exemestane (Aromasin)FDA Link 05/2007
1	Tamoxifen FDA LinkGeneric 05/2007
1	oxidized low density lipoproteinIBA 01/2006
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2006
1	CholesterolIBA 01/2006
1	LipidsIBA 12/2005
1	Insulin (Novolin)FDA Link 09/2005
1	Memantine (Namenda)FDA Link 06/2005
1	Diphosphonates (Bisphosphonates)IBA 01/2003
1	ametantrone (HAQ)IBA 09/2002
1	Interferon beta-1b (Betaseron)FDA Link 01/2002

Therapy/Procedure

11	Therapeutics 03/2024 - 01/2003
8	Patient Care 01/2017 - 04/2007
4	Activities of Daily Living (ADL) 07/2011 - 07/2007
2	Institutionalization (Institutionalized Persons) 10/2023 - 01/2020
1	Precision Medicine 01/2023
1	Stroke Rehabilitation 01/2020
1	Operative Surgical Procedures 03/2019
1	Gastrostomy 10/2018
1	Glycemic Control 09/2005
1	Length of Stay 05/2004